Operating Income: The income after operating expenses.
Oric Pharmaceuticals, Inc. (ORIC) had Operating Income of $-36.67M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-32.59M |
|
-- |
|
-- |
|
$36.67M |
|
|
Operating Income |
$-36.67M |
$4.08M |
|
$-32.59M |
|
$-32.59M |
|
$-32.59M |
|
$-32.59M |
|
$-32.59M |
|
$-32.59M |
|
$-36.67M |
|
$-36.97M |
|
98.95M |
|
98.95M |
|
$-0.33 |
|
$-0.33 |
|
| Balance Sheet Financials | |
$295.59M |
|
$2.56M |
|
$135.60M |
|
$431.19M |
|
$20.18M |
|
-- |
|
$4.09M |
|
$24.27M |
|
$406.92M |
|
$406.92M |
|
$406.92M |
|
97.28M |
|
| Cash Flow Statement Financials | |
$-88.49M |
|
$-165.01M |
|
$243.76M |
|
$59.90M |
|
$50.16M |
|
$-9.74M |
|
$18.76M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.65 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-88.97M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-8.01% |
|
-8.01% |
|
-7.56% |
|
-8.01% |
|
$4.18 |
|
$-0.90 |
|
$-0.89 |
|